{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T19:27:45Z","timestamp":1787686065678,"version":"build-2784847793"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007786","name":"National Center for Child Health and Development","doi-asserted-by":"publisher","award":["26-26"],"award-info":[{"award-number":["26-26"]}],"id":[{"id":"10.13039\/100007786","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007786","name":"National Center for Child Health and Development","doi-asserted-by":"publisher","award":["26300101"],"award-info":[{"award-number":["26300101"]}],"id":[{"id":"10.13039\/100007786","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["26-26"],"award-info":[{"award-number":["26-26"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["26300101"],"award-info":[{"award-number":["26300101"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.semarthrit.2021.07.020","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T11:00:13Z","timestamp":1627902013000},"page":"1045-1056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Monoclonal antibody and anti-cytokine biologics for Kawasaki disease: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"51","author":[{"given":"Osamu","family":"Nomura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Ishiguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2021.07.020_bib0001","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1542\/peds.54.3.271","article-title":"A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan","volume":"54","author":"Kawasaki","year":"1974","journal-title":"Pediatrics"},{"key":"10.1016\/j.semarthrit.2021.07.020_bib0002","doi-asserted-by":"crossref","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2021.07.020_bib0003","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/ped.12317","volume":"56","year":"2014","journal-title":"Pediatr Int"},{"key":"10.1016\/j.semarthrit.2021.07.020_bib0004","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1542\/peds.2004-2182","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association","volume":"114","author":"Newburger","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.semarthrit.2021.07.020_bib0005","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(11)61930-2","article-title":"Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial","volume":"9826","author":"Kobayashi","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2021.07.020_bib0006","doi-asserted-by":"crossref","first-page":"47","DOI":"10.31662\/jmaj.2018-0013","article-title":"Coronary lesions and systemic inflammatory response syndrome in Kawasaki disease","volume":"2","author":"Tomobe","year":"2019","journal-title":"JMA J"},{"key":"10.1016\/j.semarthrit.2021.07.020_bib0007","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/ped.13809","article-title":"Nationwide epidemiologic survey of Kawasaki disease in Japan, 2015\u20132016","volume":"61","author":"Makino","year":"2019","journal-title":"Pediatr Int"},{"key":"10.1016\/j.semarthrit.2021.07.020_bib0008","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0140-6736(18)32003-8","volume":"393","author":"Hamada","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2021.07.020_bib0009","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cyto.2014.07.003","article-title":"Decreased levels of inflammatory cytokines in immunoglobulin-resistant Kawasaki disease after plasma exchange","volume":"70","author":"Fujimaru","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.semarthrit.2021.07.020_bib0010","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jpeds.2008.06.011","article-title":"Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease","volume":"153","author":"Burns","year":"2008","journal-title":"J Pediatrics"},{"key":"10.1016\/j.semarthrit.2021.07.020_bib0011","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0140-6736(13)62298-9","article-title":"Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial","volume":"383","author":"Tremoulet","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2021.07.020_bib0012","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jpeds.2010.06.014","article-title":"Prospective open-label trial of etanercept as adjunctive therapy for kawasaki disease","volume":"157","author":"Choueiter","year":"2010","journal-title":"J Pediatr"},{"key":"10.1016\/j.semarthrit.2021.07.020_bib0013","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1546-0096-12-26","article-title":"High dose anakinra for treatment of severe neonatal Kawasaki disease: a case report","volume":"12","author":"Shafferman","year":"2014","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.semarthrit.2021.07.020_bib0014","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMc1709609","article-title":"Coronary-artery aneurysm in tocilizumab-treated children with Kawasaki's disease","volume":"377","author":"Nozawa","year":"2017","journal-title":"New Engl J Med"},{"key":"10.1016\/j.semarthrit.2021.07.020_bib0015","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jpeds.2012.01.018","article-title":"Resistant Kawasaki disease treated with anti-CD20","volume":"160","author":"Sauvaget","year":"2012","journal-title":"J Pediatrics"},{"key":"10.1016\/j.semarthrit.2021.07.020_bib0016","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13643-016-0236-2","article-title":"Monoclonal antibody therapy for Kawasaki disease: a protocol for systematic reviews and meta-analysis","volume":"5","author":"Nomura","year":"2016","journal-title":"Syst Rev"},{"key":"10.1016\/j.semarthrit.2021.07.020_bib0017","unstructured":"Research Committee on Kawasaki Disease. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Tokyo, Japan: Ministry of Health and Welfare, 1984."},{"key":"10.1016\/j.semarthrit.2021.07.020_bib0018","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"349","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.semarthrit.2021.07.020_bib0019","unstructured":"Green S. Cochrane handbook for systematic reviews of interventions version 5.1. 0 [updated March 2011]. The Cochrane Collaboration 2011."},{"key":"10.1016\/j.semarthrit.2021.07.020_bib0020","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence-study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.semarthrit.2021.07.020_bib0021","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2021.07.020_bib0022","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s12016-016-8581-4","article-title":"Effect and safety of TNF inhibitors in immunoglobulin-resistant Kawasaki disease: a meta-analysis","volume":"52","author":"Xue","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.semarthrit.2021.07.020_bib0023","article-title":"TNF-\u03b1 blockers for the treatment of Kawasaki disease in children","volume":"8","author":"Yamaji","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semarthrit.2021.07.020_bib0024","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/apa.14249","article-title":"Retrospective observational study indicates that the paediatric assessment triangle may suggest the severity of Kawasaki disease","volume":"107","author":"Kawai","year":"2018","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.semarthrit.2021.07.020_bib0025","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/jamapediatrics.2016.2055","article-title":"Coronary artery complication in Kawasaki disease and the importance of early intervention: a systematic review and meta-analysis","volume":"170","author":"Chen","year":"2016","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.semarthrit.2021.07.020_bib0026","article-title":"Corticosteroids for the treatment of Kawasaki disease in children","volume":"1","author":"Wardle","year":"2017","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017221001517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017221001517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:06:48Z","timestamp":1758733608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017221001517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0049017221001517"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2021.07.020","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monoclonal antibody and anti-cytokine biologics for Kawasaki disease: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2021.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}